A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of olanzapine and fluoxetine
compared to placebo and fluoxetine as treatment for treatment-resistant depression (TRD) in
Chinese participants.